semaglutide china supplier Chinese companies turn to generics as shipments behind US weight-loss craze fade Obesity and skinny craze: China

The benefit-risk profile of our GLP-1 medicines remains positive, and we welcome any new research that will improve our understanding of treatments for people living with chronic diseases.

Notably, nearly 50% of the retatrutide phase 2 obesity trial were men, which is higher than in phase 3 clinical trials with tirzepatide (32.5% in SURMOUNT-1 [27]) and semaglutide 2.4 mg (25.9% in STEP-1 [8])

Stick to the Basics of Weight Loss Taking vitamin B-12 injections may be necessary if you lack vitamin B-12 in your system

Next Steps Novo Nordisk plans to expand STEERs scope to include longer followup and additional cardiovascular endpoints